Neoplasms

Blood and Lymph Conditions

Immune System Diseases

All Conditions

Symptoms and General Pathology

Rare Diseases

Lymphoma

Lymphoma, T-Cell

Lymphoma, T-Cell, Peripheral

Lymphoma, T-Cell, Cutaneous

Graft vs Host Disease

Death

Lymphoma, Non-Hodgkin

Neoplasms by Histologic Type

Lymphoproliferative Disorders

Lymphatic Diseases

Immunoproliferative Disorders

Lymphosarcoma

Peripheral T-cell Lymphoma

Cutaneous T-cell Lymphoma

Homologous Wasting Disease

Dermatologic Agents

All Drugs and Chemicals

Methoxsalen

Sampling of 2 samples on the extracorporeal photochemotherapy circuit, before and after sensitization with 8-MOP and UVA irradiation (without additional puncture)

Samples collection

Charline VAUCHY, PhD

Charline Vauchy, PhD

Thomas CREPIN, MD

The objective of this study is to describe the type of cell death induced by extracorporeal photochemotherapy, depending on the cell type, using a panel of complementary analysis techniques.

Extracorporeal photochemotherapy (ECP) is a cell therapy used for its immunomodulation and tolerance induction capabilities. Its main indications are the control of graft-versus-host (GVH) disease in hematopoietic cell allografts, treatment and control of rejection in solid organ transplantation and the treatment of cutaneous T-cell lymphoma. Data on the mechanisms of action of ECP remains very patchy. This lack of data limits the discussion on therapeutic regimens by disease.

ECP consists of repeated apheresis sessions to collect leukocytes from the patient. The cells are then photosensitized, irradiated with UVA and reinjected into the patient in a closed circuit. In the context of GVH, induced cell death would stimulate the expansion of regulatory cells (Treg), restore a Th1/Th2 balance and decrease Th17 polarization. The ECP also allows the expansion of Treg in solid organ transplantation. Conversely, ECP would restore or activate an antitumor immune response in cutaneous T lymphoma.

The type of cells collected and treated would play a major role in the effects obtained. However, these hypotheses must be consolidated, in particular by detailing the initial role of cell death. Several questions remain, on the chronology of cell death in the different treated subpopulations, on the uptake by phagocytes, but especially on the type of cell death induced according to the cell type (necroptosis, apoptosis, pyroptosis, autophagy). The data generated will allow for validation or detail of the mechanisms of resolution of the inflammation and/or the anti-tumour effect observed.

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

MLKL (mixed lineage kinase domain-like pseudokinase) phosphorylation in Western blot

Centre Hospitalier Universitaire de Besancon

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy	NCT05333367	Cutaneous T-Cel... Graft Vs Host D... Graft Rejection	Samples collect...	18 Years - 85 Years	Centre Hospitalier Universitaire de Besancon
MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy	NCT05333367	Cutaneous T-Cel... Graft Vs Host D... Graft Rejection	Samples collect...	18 Years - 85 Years	Centre Hospitalier Universitaire de Besancon
MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy	NCT05333367	Cutaneous T-Cel... Graft Vs Host D... Graft Rejection	Samples collect...	18 Years - 85 Years	Centre Hospitalier Universitaire de Besancon

Spots Global Cancer Trial Database for extracorporeal photochemotherapy